MedTrace Logo

Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears

NCT02004730 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2014-11-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether patients with diffuse or multivessel coronary artery disease may benefit from the percutaneous implantation of the device ABSORB in larger extent with respect to the general population of patients undergoing percutaneous treatment of coronary artery disease.

Conditions

Interventions

DEVICE

ABSORB implantation

ABSORB implantation for long (\> 24mm) single vessel disease

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

    lead OTHER

Principal Investigators

  • Francesco Bedogni, MD · Istituto Clinico S. Ambrogio

  • Anna Sonia Petronio, Prof · Univ. of Pisa, Ospedale Cisanello

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-12-31
Completion
2015-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02004730 on ClinicalTrials.gov